Laobaixing Pharmacy (603883) - Total Liabilities

Latest as of March 2026: CN¥12.61 Billion CNY ≈ $1.85 Billion USD

Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥12.61 Billion CNY (≈ $1.85 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Laobaixing Pharmacy equity growth rate to track the company's year-over-year net asset growth rate.

Laobaixing Pharmacy - Total Liabilities Trend (2011–2025)

This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. See 603883 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Laobaixing Pharmacy Competitors by Total Liabilities

The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.

Company	Country	Total Liabilities
Bright Dairy & Food Co Ltd SHG:600597	China	CN¥10.89 Billion
World Kinect Corporation NYSE:WKC	USA	$5.59 Billion
Banvida SN:BANVIDA	Chile	CL$115.77 Billion
HYDROGRAPH CLEAN POWER F:M98	Germany	€2.34 Million
Dalian Dalicap Technology Co Ltd SHE:301566	China	CN¥71.78 Million
Befesa SA XETRA:BFSA	Germany	€1.09 Billion
Kosmos Energy Ltd NYSE:KOS	USA	$4.27 Billion
Global Ship Lease Inc NYSE:GSL	USA	$1.02 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603883 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.90	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laobaixing Pharmacy (2011–2025)

The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥12.85 Billion ≈ $1.88 Billion	-14.27%
2024-12-31	CN¥14.99 Billion ≈ $2.19 Billion	+7.51%
2023-12-31	CN¥13.94 Billion ≈ $2.04 Billion	-2.50%
2022-12-31	CN¥14.30 Billion ≈ $2.09 Billion	+17.41%
2021-12-31	CN¥12.18 Billion ≈ $1.78 Billion	+87.99%
2020-12-31	CN¥6.48 Billion ≈ $948.04 Million	+7.09%
2019-12-31	CN¥6.05 Billion ≈ $885.24 Million	+18.26%
2018-12-31	CN¥5.12 Billion ≈ $748.55 Million	+42.18%
2017-12-31	CN¥3.60 Billion ≈ $526.47 Million	+21.37%
2016-12-31	CN¥2.96 Billion ≈ $433.78 Million	+96.50%
2015-12-31	CN¥1.51 Billion ≈ $220.75 Million	+4.47%
2014-12-31	CN¥1.44 Billion ≈ $211.31 Million	+14.31%
2013-12-31	CN¥1.26 Billion ≈ $184.85 Million	+43.11%
2012-12-31	CN¥882.72 Million ≈ $129.17 Million	-3.30%
2011-12-31	CN¥912.83 Million ≈ $133.58 Million	--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers

Market Cap

$1.39 Billion

CN¥9.53 Billion CNY

Market Cap Rank

#7510 Global

#1655 in China

Share Price

CN¥12.56

Change (1 day)

-0.87%

52-Week Range

CN¥10.96 - CN¥18.78

All Time High

CN¥331.82